ramirez, Irma, et al. “Benefits of a National Program for Adverse Drugs Reactions (ADRS) Surveillance in Diabetic Patients”. Journal of Drug Delivery and Therapeutics, vol. 12, no. 4-S, Aug. 2022, pp. 40-42, https://doi.org/10.22270/jddt.v12i4-S.5618.